Here we demonstrate that in the Gata1low murine model of spontaneous myelofibrosis a 2‐month administration of captopril, an ACE inhibitor commonly used for the treatment of systemic hypertension, decreased bone marrow megakaryocytic hyperplasia and marrow fibrosis. This evidence concerns the gene ACE and myelofibrosis.